INS and Hypoglycemia: The Leuven I trial showed that IIT, a strict glycemic control strategy, was effective in reducing mortality in critically ill patients [10], however, severe hypoglycemia was increased by IIT, including in the VISEP (Volume Substitution and Insulin Therapy in Severe Sepsis) [11] and Glucontrol studies [12].